Friday, September 24, 2021
- Advertisement -spot_img


pharmaceutical companies

Covid vaccines and IPR

The Covid tragedy should trigger a rethink of the current intellectual property policies adopted by developed countries

China joins deal to get Covid-19 vaccine to poorer nations

The deal gives China, the country where the virus first emerged, a prominent role in the global effort to share vaccines with less-developed countries.

Rush for vaccine and ethics

Judiciary can alone ensure that exemptions given to companies for developing a vaccine are not misused

Covid-19 pushes up sales of cardiac, anti-diabetic drugs

The sudden change in preferred therapies by masses has just taken a sharp turn from pre-Covid period when gastric, vitamin therapies were most widely used.

Don’t let patent rows hamper search for virus vaccine: UN agency   

"The COVID-19 pandemic, which has killed over 350,000 people out of the more than 5.5 million infected worldwide, certainly represents such an emergency."

Telangana: Villagers demand closure of pharma units in Polepally SEZ

Despite the lockdown, some companies in Polepally have been operating, as the medicines made here are exported abroad. Due to thousands of workers in these companies coming into the village and going back

Indian pharma exports set to grow

The Pharmaceutical Export Promotion Council of India (Pharmexcil), Ministry of Commerce and Industry, has projected over 10 per cent growth in pharma exports from India during this fiscal at or over $19 billion.

The sapphire in cyber security space

Kiran Vangaveti-founded company to expand its operations in the US, Europe, Middle East and Asia

Now, ‘track and trace’ your medicine

Digital numbers to be provided by pharma companies will enable regulators to track the origin of the drugs

Cancer biologicals to bring in new hope, say experts at BioAsia

Presenting his key note address, Dr Shreeram said, Novartis is making efforts to carry out research on several areas including cancer in India and the nation is a key hub for all its global activities.

Pulsus plans to buy two firms

To set up new centres in Chennai and Gurugram this year

Central team to interact with clinical trial victim in Telangana

Following the incident in which three persons, all hailing from Jammikunta area in Karimnagar, displayed adverse reactions after participating in drugs trials, the State government on its part had alerted CDSCO for further action.

GVK Bio ramping up operations

To invest Rs 200-250 crore in two years; integrate US operations

End the nexus

One of the key issues facing India’s healthcare sector is the unholy nexus between profit-driven pharmaceutical companies and doctors. It often works to the...

Hyderabad pharma firms show good results

For the full year, the company saw net profit rising 13.7 per cent at Rs 2,301.2 crore, while total income was up 7.3 per cent to Rs 15,205.75 crore over the previous fiscal.

Latest news

- Advertisement -spot_img
Telangana Today